Paradigm Biocapital Advisors LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $2.77 Billion distributed in 33 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Nuvalent, Inc. with a value of $512M, Arcellx, Inc. with a value of $334M, Argenx Se with a value of $261M, Revolution Medicines, Inc. with a value of $241M, and Crinetics Pharmaceuticals, Inc. with a value of $129M.
Examining the 13F form we can see an increase of $304M in the current position value, from $2.47B to 2.77B.
Paradigm Biocapital Advisors LP is based out at New York, NY
Below you can find more details about Paradigm Biocapital Advisors LP portfolio as well as his latest detailed transactions.
